Fit and Trim Weight Loss Clinic

Fit and Trim Weight Loss Clinic operates as a medical weight loss facility in North Andover, Massachusetts, focusing exclusively on non-surgical interventions for patients seeking clinically supervised weight reduction. The clinic has built its practice around compounded GLP-1 receptor agonist medications and growth hormone-releasing peptides, offering structured programs that combine pharmaceutical intervention with metabolic monitoring. Unlike general wellness centers that incorporate weight management as one of many services, Fit and Trim concentrates its clinical protocols specifically on obesity medicine and metabolic optimization through peptide-based therapies.

The clinic's formulary centers on three primary peptide medications: Semaglutide and Tirzepatide as GLP-1 receptor agonists for appetite regulation and glycemic control, and Sermorelin as a growth hormone secretagogue for metabolic enhancement. Semaglutide protocols at the facility utilize compounded formulations that allow for individualized dosing adjustments based on patient tolerance and response patterns, with titration schedules modified according to side effect profiles and weight loss velocity. Tirzepatide represents the clinic's dual GIP/GLP-1 receptor agonist option for patients who may benefit from the combined incretin effect on insulin secretion and gastric emptying. Sermorelin therapy is incorporated for patients whose treatment plans include optimization of growth hormone pathways to support lean muscle preservation during caloric restriction, addressing the common clinical challenge of maintaining metabolic rate during significant weight reduction.

Fit and Trim Weight Loss Clinic requires in-person consultations at its North Andover location, where initial assessments include metabolic panel review, body composition analysis, and medical history evaluation to determine peptide therapy candidacy. The clinic's providers evaluate contraindications specific to GLP-1 medications, including personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2, before initiating treatment protocols. Patients receive injection training during their initial visits, with the clinic providing detailed instruction on subcutaneous administration technique, injection site rotation, and proper medication storage. Follow-up scheduling is structured around medication titration phases, with more frequent visits during dose escalation periods when gastrointestinal side effects are most likely to occur.

The patient experience at Fit and Trim involves regular weight monitoring, medication adjustment based on tolerance and efficacy, and ongoing assessment of metabolic markers throughout the treatment course. The clinic's approach addresses the practical aspects of peptide therapy adherence, including management of common GLP-1 side effects such as nausea, constipation, and reduced appetite that can affect treatment continuation. Patients working with Semaglutide or Tirzepatide typically follow protocols that span several months, with dosage increases occurring at four-week intervals until therapeutic targets are achieved or maximum tolerated doses are reached. The inclusion of Sermorelin in treatment plans provides an additional mechanism for patients concerned about loss of lean body mass, as this growth hormone-releasing hormone analog stimulates endogenous growth hormone production that supports protein synthesis and metabolic rate maintenance.

Fit and Trim Weight Loss Clinic's focus on compounded medications allows for formulation flexibility not available with standard commercial products, including the ability to adjust concentrations and combine therapies based on individual patient requirements. The North Andover clinic serves patients throughout the Merrimack Valley region of Massachusetts, with its in-person consultation requirement ensuring direct provider oversight of peptide therapy initiation and management. The clinic's specialization in medical weight loss through peptide interventions positions it as a resource for patients who have not achieved sustainable results through lifestyle modification alone and are seeking pharmaceutical support within a monitored clinical framework. With 16 patient reviews averaging 4.5 stars and specific mention of injection protocols and Semaglutide experiences, the clinic has established a track record in delivering peptide-based weight loss interventions to the North Andover community.